Location History:
- Reims Cedex 2, FR (2006 - 2008)
- Reims Cedex, FR (2009)
Company Filing History:
Years Active: 2006-2009
Title: Innovations of Jean Claude Arnould
Introduction
Jean Claude Arnould is a notable inventor based in Reims, France. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 4 patents to his name, Arnould's work has implications in pharmaceutical applications.
Latest Patents
Arnould's latest patents focus on chemical compounds that serve as gonadotropin-releasing hormone antagonists. The first patent describes a group of novel thieno-pyrrole compounds of Formula (I), which are defined in the specification. These compounds are useful in pharmaceutical formulations and methods of treatment. The second patent also relates to thieno-pyrrole compounds, emphasizing their role as antagonists of gonadotropin-releasing hormone. Both inventions include processes for the preparation of these compounds, showcasing Arnould's innovative approach to drug development.
Career Highlights
Jean Claude Arnould is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on the development of therapeutic solutions that address critical health issues. His expertise in chemical compounds has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Arnould has collaborated with notable colleagues, including Kevin Michael Foote and Zbigniew Stanley Matusiak. These collaborations have likely contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Jean Claude Arnould's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative work on thieno-pyrrole compounds demonstrates his commitment to advancing medical science. With a solid foundation of patents and collaborations, Arnould continues to make an impact in his field.